1. Qumseya B, Sultan S, Bain P, Jamil L, Jacobson B, Anandasabapathy S, et al. ASGE guideline on screening and surveillance of Barrett’s esophagus. Gastrointest Endosc. 2019;90:335–59.e2.
2. Pimentel-Nunes P, Libânio D, Marcos-Pinto R, Areia M, Leja M, Esposito G, et al. Management of epithelial precancerous conditions and lesions in the stomach (maps ii): European Society of Gastrointestinal Endoscopy (esge), European helicobacter and microbiota study group (ehmsg), European Society of Pathology (esp), and sociedade Portuguesa de endoscopia digestiva (sped) guideline update 2019. Endoscopy. 2019;51:365–88.
3. Lordick F, Mariette C, Haustermans K, Obermannová R, Arnold D, Committee EG. Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27:v50–7.
4. Kerkhof M, Van Dekken H, Steyerberg EW, Meijer GA, Mulder AH, de Bruïne A, et al. Grading of dysplasia in Barrett’s oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology. 2007;50:920–7.
5. Curvers WL, ten Kate FJ, Krishnadath KK, Visser M, Elzer B, Baak LC, et al. Low-grade dysplasia in Barrett’s esophagus: overdiagnosed and underestimated. Am J Gastroenterol. 2010;105:1523–30.